Andrew Krystal, M.D., is a board-certified clinical neurophysiologist and internationally recognized expert in sleep and mood disorders with over 25 years of clinical and research experience. After earning a master’s in biomechanical engineering from MIT, Krystal completed medical school, psychiatric residency, and fellowships in sleep medicine and neurophysiology at Duke University. He has led more than 50 clinical trials and is known for pioneering computational EEG modeling to identify biomarkers in depression and insomnia.
Krystal’s work focuses on how sleep affects brain function and its role in psychiatric disorders. He is passionate about developing novel treatments for sleep disorders and advancing biomarker-driven clinical research. He currently serves as director of the Clinical and Translational Sleep Research Program at UCSF and holds the Ray and Dagmar Dolby Distinguished Professorship. He is president of the Sleep Research Society and an active member of the American Academy of Sleep Medicine, APA, and ACNP.
